© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Questions remain about whether people with HIV are more at risk for severe COVID-19, as evidence to date is mixed.
Smoking is also associated with heart disease and several types of cancer.
An ongoing randomized controlled trial will provide more definitive results in the future.
Should people interested in PrEP be able to access it through the mental health system?
In a series of reports, HIV experts lay out the gaps in plans to end the epidemic and ways to fix them.
Research suggests protective effect of natural infection or vaccination is likely to be persistent.
Across the life span, non-plaque-related causes of heart attack were more common in people with HIV.
However, all integrase inhibitors were associated with similar weight gain.
13,000 gay and bi Black and Latino men received PrEP care through collaboratives.
However, even as new cases climbed, deaths declined.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Compared with efavirenz-based regimens, dolutegravir-containing ones resulted in fewer switches and better viral control.
The São Paulo Patient is no longer HIV-free after more than 15 months off treatment, but was it a relapse or reinfection?
Increased HCV testing and treatment for both HIV-positive and HIV-negative gay and bi men could help eliminate hep C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
